COST PLUS FIXED FEE

RHO FEDERAL SYSTEMS DIVISION INC - INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

PIID: 75A50122F33004

Signed Date: Oct 22, 2025Effective Date: Sep 27, 2022End Date: Closed on Sep 26, 2026

Award $

$3.0M

Vendor

RHO FEDERAL SYSTEMS DIVISION INC

NAICS

541715

Signed Date

Oct 22, 2025

Key Details

Dollars Obligated

$3.0M

Base & All Options

Awarding Agency

Awarding Sub-Agency

Office of Assistant Secretary for Preparedness and Response

NAICS Code

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

DURHAM, NC, 277137444, CD-NC-04

INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.

On Oct 22, 2025, Department of Health and Human Services obligated $2,983,502 to RHO FEDERAL SYSTEMS DIVISION INC for integrated safety summary report of clinical studies assessing safety of influenza vaccines administered with as03 or mf59 adjuvant.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.